Back to News
Market Impact: 0.2
BioRadar Names David Relman and Kevin Esvelt Co-Chairs of Scientific Advisory Board
Source: PR Newswire
Healthcare & BiotechTechnology & InnovationPandemic & Health EventsManagement & Governance
BioRadar named Stanford's Dr. David Relman and MIT's Dr. Kevin Esvelt co-chairs of its Scientific Advisory Board. They will help lead the science behind the company's biological early-warning platform, described as a “biological weather service”; the announcement provides no financial or market data.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
mildly positive
Sentiment Score
0.25
More News
- Elon Musk blames Indian 'oligarchs' for stalling Starlink launch
- Former world No. 1 Jon Rahm's lawyer tells court Spaniard is done with LIV Golf after three seasons
- FCC to vote on auctioning 25MHz of 'prime spectrum' in move that could benefit Amazon, SpaceX
- Microsoft shows off new Windows software, revamped for agentic AI
- Wolfspeed secures $1.5 billion conditional loan commitment from US defense department
- Microsoft to sell $2,599 Surface Laptop Ultra containing Nvidia AI chip